Disrupted insulin signaling in the brain and the hypothalamic–pituitary–adrenal axis has been proposed as one explanation for the comorbidity of mood disorders and obesity [70]. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.